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Abstract
Background: Aortic valve insufficiency (AI) at the time of left ventricular assist device (LVAD) insertion needs to be
corrected, however there is little known about how to manage bioprosthetic valvular AI.
Case presentation: A 55-year-old female with dilated cardiomyopathy who previously had a bioprosthetic aortic valve
replacement needed a LVAD as a bridge to transplant. Her left ventricular ejection fraction was 10% and had mild to
moderate transvalvular AI. She underwent a HeartWare HVAD insertion along with aortic valvular coaptation stitch repair
(Park's stitch) to the bioprosthetic valve.
Conclusion: Her AI improved to trivial with minimal ejection through the bioprosthetic valve. She was transplanted
6 months following the surgery. A Park's stitch to the bioprosthetic aortic valve with more than mild AI might be a
good option for bridge to transplant patient.
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Background
Continuous flow left ventricular assist devices (LVADs)
are known to cause progressive aortic valve commissural
fusion as well as progressive aortic insufficiency with
greater pump speeds and larger aortic root dimensions
[1, 2]. Currently, consensus is to intervene on the aortic
valve at the time of LVAD implant if the patient has
more than mild aortic insufficiency (AI) (Class I, Level
of Evidence C) [3]. The aortic valve can either be
repaired or replaced with a bioprosthetic valve. The
central coaptation repair stitch (Park’s stitch) has been
shown to effectively and durably reduce the AI as well
as improve survival, while maintaining aortic valve
opening to allow ejection, without the additional
cardiopulmonary bypass time that would be required
for bioprosthetic valve replacement [4, 5]. This tech-
nique has typically been applied to native aortic valves
in patients who present with significant AI at the time
of LVAD implantation, but there is little known about
the application of this technique to patients who
present with bioprosthetic transvalvular aortic valve
insufficiency at time of LVAD implant. This report
demonstrates first clinical application of a Park’s stitch
to a patient with a previous bioprosthetic aortic valve
replacement (AVR) developing transvalvular AI.
Case presentation
A 55 year-old female with non-ischemic cardiomyopathy
who initially presented with multiple syncopal episodes and
increasing shortness of breath on exertion for the preceding
2 months. Her left ventricular ejection fraction (LVEF) was
20% at that time, with severe aortic stenosis and mild AI.
Her aortic valve area was 1.0 cm2, with a peak gradient
16.9 mmHg and mean gradient 9.2 mmHg gradient. She
underwent AVR with a 21 mm Mitroflow (Sorin, Milan,
Italy) bioprosthetic valve with significant improvement in
her symptoms (aortic valve area 1.8cm2, peak gradient
18.2 mmHg and mean gradient 9.0 mmHg).
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Over the next 2 months, the patient had worsening
heart failure with a decline in her LVEF to 15%. Her
medical regimen was optimized with some improvement
in her symptoms initially, however the improvement was
short lived. Subsequent echocardiograms showed 15%
LVEF, with new mild to moderate intra-valvular AI and
mild perivalvular leak. Seven months after her AVR the
patient was severely short of breath with declining
ventricular function and mild to moderate AI. Her right
ventricular function was severely depressed. The decision
was made to insert HeartWare HVAD (Framingham, MA)
with prosthetic aortic valve repair, Park’s stitch. Her
INTERMACS profile was 3. Her pre operative platelet
count, prothrombin time, and INR were 138 (1000/μl),
14.5 s, and 1.1. At the time of her LVAD insertion, the
repair stitch was able to minimize her ischemic time to
help preserve her RV. A pledgeted 4-0 Prolene (Ethicon,
Cincinnati, OH) was placed to center of the each aortic
valve leaflet. We could not appreciate perivalvular leak in-
traoperatively, however pledgeted mattressed 2-0 ethibond
sutures were passed through from subvalvular leaflets to
aortic wall and tied over pledgets. No obvious leaflet
prolapse or perforation was noted (Fig. 1). The cardiopul-
monary bypass time was 167 min and myocardial ische-
mic time was 52 min. Post-operatively, the patient had no
AI on transesophageal echocardiogram as well as limited
ejection through the aortic valve. The anticoagulation
management was aspirin 325 mg/day and continuous
heparin infusion based on thromboelastogram until
Coumadin gets therapeutic, INR 2-3. She recovered
well and was discharged home at postoperative day 27.
At 4 months post HVAD insertion, the patient was
feeling well with only trace AI on transthoracic echocar-
diogram. She developed lacunar infarction within the
ventromedial nucleus of the right thalamus on 3 months
after LVAD insertion. She was heart transplanted at
Fig. 1 Pre and post op aortic valve insufficiency. There was intra-valvular aortic insufficiency in pre op aortic valve (a), no aortic insufficiency was
noted after aortic valve coaptation stitch (b)
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6 months following her LVAD insertion. Her aortic valve
was fused and closed. No thrombus formation underneath
the aortic valve was noted (Fig. 2).
Conclusion
Little has been known about management of recurrent
AI after bioprosthetic AVR at the time of LVAD place-
ment. A central coaptation stitch to these patients poten-
tially is a good option for a bridge to transplant.
Short-term follow up in this patient shows promising
results with only trace AI on echocardiogram. Although
this technique has been shown to be a durable solution
for patients with significant native aortic valve insufficiency
[4], the long-term results of this technique especially in
bioprosthetic valves remains to be seen to determine the
durability of these results in the face of continued biopros-
thetic valve degeneration.
Although there have been numerous studies of AI in
LVAD patients, we don't know the long-term prognosis of
patients who develops acquired AI. Since AI seemed to
have negative impact on survival [1, 6], either biopros-
thetic AVR or aortic valve repair is recommended for
these patients. Patients with AI with following a previous
bioprosthetic AVR, no recommendation is currently avail-
able. Performing a re-replacement bioprosthetic AVR may
be more durable to prevent leaflet fusion, however
explanting a previous valve and re-implant new valve in
patients having an LVAD placement with concomitant
severe RV dysfunction raises concerns about further
impairing postoperative RV function. A Park's stitch to a
bioprosthetic AVR is relatively easy, timely, safe and
durable in LVAD patients being bridged to transplant.
This procedure was able to be performed in a quick
and effective manner with short aortic cross clamp time
to minimize the risk of RV dysfunction after LVAD
placement.
The limitation of this technique in the setting of previous
bioprosthetic AVR is no long-term mortality and morbidity
data reported, therefore the application of this technique to
destination patients should be cautious because of aortic
valve leaflet fusion and potential thrombus formation below
the fused aortic valve. If patients with AI from degenerating
bioprosthetic AVR is listed as bridge to transplant, a Park's
stitch to the bioprosthetic valve leaflets might be a good
option to consider.
In conclusion, we reported a first successful case with
Park's stitch and LVAD placement to previously placed
bioprosthetic AVR. Further studies are mandatory to
prove longevity and survival of this procedure in this
context.
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